Lars Navér

2.3k total citations
64 papers, 936 citations indexed

About

Lars Navér is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lars Navér has authored 64 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 24 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Lars Navér's work include HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (24 papers) and HIV/AIDS drug development and treatment (16 papers). Lars Navér is often cited by papers focused on HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (24 papers) and HIV/AIDS drug development and treatment (16 papers). Lars Navér collaborates with scholars based in Sweden, United States and United Kingdom. Lars Navér's co-authors include Katarina Westling, Britt‐Marie Ygge, Lars E. Eriksson, Jan Albert, Susanne Lindgrén, Lars L. Gustafsson, Mikael Norman, Magnus Gisslén, Christian G. Giske and Erik Belfrage and has published in prestigious journals such as JAMA, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Lars Navér

60 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Navér Sweden 20 430 289 256 220 143 64 936
Natalie Neu United States 18 515 1.2× 489 1.7× 110 0.4× 129 0.6× 56 0.4× 67 1.1k
Amy L. Slogrove South Africa 16 724 1.7× 361 1.2× 187 0.7× 157 0.7× 148 1.0× 69 1.2k
Nicole H. Tobin United States 21 787 1.8× 343 1.2× 498 1.9× 127 0.6× 201 1.4× 49 1.5k
George Kafulafula Malawi 20 792 1.8× 493 1.7× 291 1.1× 162 0.7× 136 1.0× 32 1.3k
Russell Van Dyke United States 18 914 2.1× 552 1.9× 266 1.0× 193 0.9× 49 0.3× 38 1.4k
Hopkins Dr United States 3 462 1.1× 339 1.2× 275 1.1× 120 0.5× 68 0.5× 8 1000
Joseph I. Harwell United States 20 581 1.4× 365 1.3× 198 0.8× 82 0.4× 30 0.2× 49 988
Christian Kind Switzerland 20 1.0k 2.3× 467 1.6× 472 1.8× 175 0.8× 59 0.4× 49 1.4k
Ersilia Buonomo Italy 16 628 1.5× 272 0.9× 158 0.6× 75 0.3× 59 0.4× 78 956
Claire von Mollendorf United States 19 407 0.9× 735 2.5× 97 0.4× 96 0.4× 33 0.2× 61 1.1k

Countries citing papers authored by Lars Navér

Since Specialization
Citations

This map shows the geographic impact of Lars Navér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Navér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Navér more than expected).

Fields of papers citing papers by Lars Navér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Navér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Navér. The network helps show where Lars Navér may publish in the future.

Co-authorship network of co-authors of Lars Navér

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Navér. A scholar is included among the top collaborators of Lars Navér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Navér. Lars Navér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navér, Lars, Henrik Ljungberg, Anna Nordlander, et al.. (2025). Updated Swedish guidelines for the management and treatment of RSV infection. Infectious Diseases. 58(1). 150–163.
2.
Navér, Lars, Jan Albert, Christina Carlander, et al.. (2024). Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024. Infectious Diseases. 56(8). 657–668.
3.
Domellöf, Magnus, et al.. (2024). Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trial. EClinicalMedicine. 68. 102375–102375. 16 indexed citations
4.
Belfrage, Erik, et al.. (2023). Growth, weight gain and BMI in virally suppressed children on antiretroviral therapy with specific reference to dolutegravir. BMC Pediatrics. 23(1). 339–339. 3 indexed citations
5.
Duignan, Sophie, Satyan Lakshminrusimha, Kathryn Armstrong, et al.. (2023). Neonatal sepsis and cardiovascular dysfunction I: mechanisms and pathophysiology. Pediatric Research. 95(5). 1207–1216. 3 indexed citations
6.
Shah, Prakesh S., Chloë Joynt, Stellan Håkansson, et al.. (2022). Infants Born to Mothers Who Were SARS-CoV-2 Positive during Pregnancy and Admitted to Neonatal Intensive Care Unit. Neonatology. 119(5). 619–628. 3 indexed citations
7.
Ahlsson, Fredrik, et al.. (2021). Nordic study on human milk fortification in extremely preterm infants: a randomised controlled trial—the N-forte trial. BMJ Open. 11(11). e053400–e053400. 7 indexed citations
8.
Jönsson, Kerstin, Christian G. Giske, Aina Iversen, et al.. (2018). Neonatal intestinal colonization with extended-spectrum β-lactamase–producing Enterobacteriaceae—a 5-year follow-up study. Clinical Microbiology and Infection. 24(9). 1004–1009. 19 indexed citations
9.
Bekele, Yonas, Aikaterini Nasi, Maurizio Zazzi, et al.. (2018). Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?. Frontiers in Immunology. 8. 1966–1966. 2 indexed citations
10.
Westling, Katarina, et al.. (2018). Dolutegravir in pregnancy—effects on HIV-positive women and their infants. European Journal of Clinical Microbiology & Infectious Diseases. 37(3). 495–500. 17 indexed citations
11.
Westling, Katarina, Lars Navér, Jan Vesterbacka, & Erik Belfrage. (2016). Transition of HIV-infected youths from paediatric to adult care, a Swedish single-centre experience. Infectious Diseases. 48(6). 449–452. 21 indexed citations
12.
13.
Westling, Katarina, et al.. (2012). Rapid Decline in HIV Viral Load When Introducing Raltegravir-Containing Antiretroviral Treatment Late in Pregnancy. AIDS Patient Care and STDs. 26(12). 714–717. 26 indexed citations
14.
Navér, Lars, et al.. (2012). Impaired neutralizing activity by transplacental measles antibodies in infants born to HIV‐1‐infected mothers. Acta Paediatrica. 101(11). e500–4. 4 indexed citations
15.
Parham, Leda, et al.. (2011). Short Communication: High Prevalence of Drug Resistance in HIV Type 1-Infected Children Born in Honduras and Belize 2001 to 2004. AIDS Research and Human Retroviruses. 27(10). 1055–1059. 6 indexed citations
16.
Josephson, Filip, Jan Albert, Leo Flamholc, et al.. (2009). Treatment of HIV infection: Swedish recommendations 2009. Scandinavian Journal of Infectious Diseases. 41(11-12). 788–807. 14 indexed citations
17.
Navér, Lars, Susanne Lindgrén, Erik Belfrage, et al.. (2006). Children Born to HIV-1-Infected Women in Sweden in 1982-2003. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(4). 484–489. 42 indexed citations
18.
Clevestig, Peter, Irina Maljkovic Berry, Charlotte Casper, et al.. (2005). The X4 Phenotype of HIV Type 1 Evolves from R5 in Two Children of Mothers, Carrying X4, and Is Not Linked to Transmission. AIDS Research and Human Retroviruses. 21(5). 371–378. 21 indexed citations
19.
Barqasho, Babilonia, et al.. (2004). GB virus C coinfection and vertical transmission in HIV‐infected mothers before the introduction of antiretroviral prophylaxis. HIV Medicine. 5(6). 427–430. 8 indexed citations
20.
Casper, Charlotte, Lars Navér, Peter Clevestig, et al.. (2002). Coreceptor Change Appears after Immune Deficiency Is Established in Children Infected with Different HIV-1 Subtypes. AIDS Research and Human Retroviruses. 18(5). 343–352. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie Neu Breakdown of academic impact, for papers by Amy L. Slogrove Breakdown of academic impact, for papers by Nicole H. Tobin Breakdown of academic impact, for papers by George Kafulafula Breakdown of academic impact, for papers by Russell Van Dyke Breakdown of academic impact, for papers by Hopkins Dr Breakdown of academic impact, for papers by Joseph I. Harwell Breakdown of academic impact, for papers by Christian Kind Breakdown of academic impact, for papers by Ersilia Buonomo Breakdown of academic impact, for papers by Claire von Mollendorf
Rankless by CCL
2026